SU602121A3 - Способ получени -гомостероидов - Google Patents
Способ получени -гомостероидовInfo
- Publication number
- SU602121A3 SU602121A3 SU752180252A SU2180252A SU602121A3 SU 602121 A3 SU602121 A3 SU 602121A3 SU 752180252 A SU752180252 A SU 752180252A SU 2180252 A SU2180252 A SU 2180252A SU 602121 A3 SU602121 A3 SU 602121A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- solution
- methanol
- water
- added
- rotary evaporator
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 7
- 150000000795 D-homosteroids Chemical class 0.000 title description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 63
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 18
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 12
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 8
- 235000006408 oxalic acid Nutrition 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 claims description 2
- -1 chloroethynyl Chemical group 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 102100035475 Blood vessel epicardial substance Human genes 0.000 claims 1
- 101001094636 Homo sapiens Blood vessel epicardial substance Proteins 0.000 claims 1
- 101000608194 Homo sapiens Pyrin domain-containing protein 1 Proteins 0.000 claims 1
- 101000595404 Homo sapiens Ribonucleases P/MRP protein subunit POP1 Proteins 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims 1
- 238000005903 acid hydrolysis reaction Methods 0.000 claims 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 230000007062 hydrolysis Effects 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 claims 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims 1
- 229920002554 vinyl polymer Polymers 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 39
- 239000000243 solution Substances 0.000 description 26
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 20
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 16
- 229910052938 sodium sulfate Inorganic materials 0.000 description 14
- 235000011152 sodium sulphate Nutrition 0.000 description 14
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 12
- 239000012074 organic phase Substances 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 8
- 239000005977 Ethylene Substances 0.000 description 7
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 6
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 238000004587 chromatography analysis Methods 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 239000005457 ice water Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000000741 silica gel Substances 0.000 description 6
- 229910002027 silica gel Inorganic materials 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 238000010828 elution Methods 0.000 description 5
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 239000012043 crude product Substances 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 3
- 229910052786 argon Inorganic materials 0.000 description 3
- 239000012300 argon atmosphere Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- ODWXUNBKCRECNW-UHFFFAOYSA-M bromocopper(1+) Chemical compound Br[Cu+] ODWXUNBKCRECNW-UHFFFAOYSA-M 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000012456 homogeneous solution Substances 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- ZXSQEZNORDWBGZ-UHFFFAOYSA-N 1,3-dihydropyrrolo[2,3-b]pyridin-2-one Chemical compound C1=CN=C2NC(=O)CC2=C1 ZXSQEZNORDWBGZ-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000007818 Grignard reagent Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 1
- XMWLGNXNARHLRX-UHFFFAOYSA-N [Li].C#C.NCCN Chemical compound [Li].C#C.NCCN XMWLGNXNARHLRX-UHFFFAOYSA-N 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- NPOMSUOUAZCMBL-UHFFFAOYSA-N dichloromethane;ethoxyethane Chemical compound ClCCl.CCOCC NPOMSUOUAZCMBL-UHFFFAOYSA-N 0.000 description 1
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Substances OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 1
- 229910052808 lithium carbonate Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- CKJRQPWAXMFUCK-UHFFFAOYSA-N methane;propan-2-one Chemical compound C.CC(C)=O CKJRQPWAXMFUCK-UHFFFAOYSA-N 0.000 description 1
- MWWATHDPGQKSAR-UHFFFAOYSA-N propyne Chemical compound CC#C MWWATHDPGQKSAR-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 229910001958 silver carbonate Inorganic materials 0.000 description 1
- LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- KFUSEUYYWQURPO-OWOJBTEDSA-N trans-1,2-dichloroethene Chemical group Cl\C=C\Cl KFUSEUYYWQURPO-OWOJBTEDSA-N 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1398974A CH606113A5 (enrdf_load_stackoverflow) | 1974-10-18 | 1974-10-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU602121A3 true SU602121A3 (ru) | 1978-04-05 |
Family
ID=4397020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU752180252A SU602121A3 (ru) | 1974-10-18 | 1975-10-16 | Способ получени -гомостероидов |
Country Status (27)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL51468A (en) * | 1976-02-23 | 1981-01-30 | Sparamedica Ag | 17 -hydroxy- -d-homosteroid derivatives,their preparation and pharmaceutical compositions containing them |
| US4788218A (en) * | 1984-05-21 | 1988-11-29 | Sri International | 17 a β-hydroxy-7 α-methyl-d-homo-19-norandrost-4,16-diene-3-one and the 17-esters thereof: methods of preparation and uses |
| FI860253A7 (fi) * | 1984-05-21 | 1986-01-20 | Stanford Res Inst Int | 17a -hydroksi-7 -metyyli-D-homo -19-norandrost-4,16-dien-3-oni ja sen 17a -esterit ja menetelmä näiden yhdisteiden valmistamiseksi. |
-
1974
- 1974-10-18 CH CH1398974A patent/CH606113A5/xx not_active IP Right Cessation
-
1975
- 1975-10-01 ZA ZA00756243A patent/ZA756243B/xx unknown
- 1975-10-03 IL IL48239A patent/IL48239A/xx unknown
- 1975-10-07 FI FI752797A patent/FI53974C/fi not_active IP Right Cessation
- 1975-10-15 FR FR7531502A patent/FR2287902A1/fr active Granted
- 1975-10-15 NZ NZ178880A patent/NZ178880A/xx unknown
- 1975-10-15 CA CA237,710A patent/CA1052768A/en not_active Expired
- 1975-10-16 DD DD188897A patent/DD123331A5/xx unknown
- 1975-10-16 SU SU752180252A patent/SU602121A3/ru active
- 1975-10-16 PH PH17667A patent/PH13491A/en unknown
- 1975-10-16 LU LU73595A patent/LU73595A1/xx unknown
- 1975-10-16 JP JP50123871A patent/JPS5165750A/ja active Pending
- 1975-10-16 SE SE7511640A patent/SE7511640L/ not_active Application Discontinuation
- 1975-10-17 AT AT793775A patent/AT348697B/de not_active IP Right Cessation
- 1975-10-17 BE BE161009A patent/BE834597A/xx unknown
- 1975-10-17 DK DK469975AA patent/DK137088B/da unknown
- 1975-10-17 NO NO753505A patent/NO142349C/no unknown
- 1975-10-17 GB GB4263775A patent/GB1477567A/en not_active Expired
- 1975-10-17 PL PL1975184060A patent/PL100429B1/pl unknown
- 1975-10-17 IE IE2264/75A patent/IE42024B1/en unknown
- 1975-10-17 ES ES441863A patent/ES441863A1/es not_active Expired
- 1975-10-17 NL NL7512221A patent/NL7512221A/xx not_active Application Discontinuation
- 1975-10-17 DE DE19752546613 patent/DE2546613A1/de not_active Withdrawn
- 1975-10-17 HU HU75HO1848A patent/HU174009B/hu unknown
-
1977
- 1977-11-10 CH CH1371977A patent/CH618446A5/de not_active IP Right Cessation
-
1979
- 1979-06-25 NO NO792125A patent/NO143503C/no unknown
-
1980
- 1980-07-07 KE KE3062A patent/KE3062A/xx unknown
- 1980-08-07 HK HK405/80A patent/HK40580A/xx unknown
-
1981
- 1981-12-30 MY MY137/81A patent/MY8100137A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU602121A3 (ru) | Способ получени -гомостероидов | |
| SU676170A3 (ru) | Способ получени 7-оксиэстрадиолов | |
| US2949476A (en) | 16-alkylestratriene-3, 16, 17-triols and derivatives thereof | |
| US2759929A (en) | Compounds for synthesizing steroids | |
| US3413288A (en) | Process for the production of steroidal c-17 spirolactones | |
| US3009934A (en) | 2beta-halo-3alpha-hydroxy-5alpha-androstan-17-ones and derivatives thereof | |
| US2723280A (en) | 1-methyl-17-ethinyl-estradiol | |
| US5516922A (en) | Process for the preparation of 10(2-propynyl)estr-4-ene-3,17-dione | |
| US2855413A (en) | 16-haloestradiol esters and ethers | |
| US3673175A (en) | Preparation of piperidyl-steroids | |
| SU679147A3 (ru) | Способ получени правовращающих гомостероидов | |
| US3470216A (en) | Selected 17,17-difluoro unsaturated androstanes | |
| US3313703A (en) | 19-nor-deta4, 9, 11-pregnatriene-3, 20-dione, process and intermediates | |
| PL118827B1 (en) | Method of manufacture of tricyclicdiketone | |
| US3766248A (en) | Substituted tricyclic compounds and process for their preparation | |
| US3083200A (en) | 22-halo-20-spirox-4-ene-3, 21-diones and process for preparation | |
| US2835681A (en) | Method of preparing alpha-estradiol | |
| IL26986A (en) | 7alpha-methyl-delta4,9-steroids of the estrane and gonane series | |
| HU187843B (en) | Process for producing 17-alpha-hydroxy-17-beta-bracket-hydroxy-acetyl-bracket closed-steroides | |
| US3418326A (en) | 5-alkyl-13-polycarbon-gonanes | |
| IL23453A (en) | Process for the preparation of 17alpha-ethynyl-19-nor steroids | |
| US2495735A (en) | Process for preparing lower alkyl esters of 3-hydroxy-11-keto-12-bromonorcholanic acid | |
| US3975412A (en) | Mono-acylation of 17-hydroxy-3-alkoxygona-2,5-(10)dienes | |
| US3763194A (en) | Biologically active 17alpha-ethynyl-16,17-dihydroxy-13-alkylgona-1,3,5(10)-trienes | |
| US3888849A (en) | 17' -substituted-allene-bearing steroids |